CELEX: 62016TN0662
Language: en
Date: 2016-09-12 00:00:00
Title: Case T-662/16: Action brought on 12 September 2016 — Gall Pharma v EUIPO — Pfizer (Styriagra)

28.11.2016   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 441/19
            
         
      Action brought on 12 September 2016 — Gall Pharma v EUIPO — Pfizer (Styriagra)
      (Case T-662/16)
      (2016/C 441/24)
      Language in which the application was lodged: German
      
         Parties
      
      
         Applicant: Gall Pharma GmbH (Judenburg, Austria) (represented by: D. Reichelt and L. Figura, lawyers)
      
         Defendant: European Union Intellectual Property Office (EUIPO)
      
         Other party to the proceedings before the Board of Appeal: Pfizer Inc. (New York, New York, United States)
      
         Details of the proceedings before EUIPO
      
      
         Applicant for registration of the trade mark at issue: Applicant
      
         Trade mark at issue: EU word mark ‘Styriagra’ — EU trade mark application No 12 161 469
      
         Proceedings before EUIPO: Opposition proceedings
      
         Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 13 June 2016 in Case R 724/2015-5
      
         Form of order sought
      
      The applicant claims that the Court should:
      
                  —
               
               
                  annul the contested decision and reject the opposition (Opposition Procedure No 002286568) to Community trade mark No 000233890;
               
            
                  —
               
               
                  order the defendant to pay the costs.
               
            
         Pleas in law
      
      
                  —
               
               
                  Infringement of Article 8(5) of Regulation No 207/2009;
               
            
                  —
               
               
                  Infringement of Article 8(1)(b) of Regulation No 207/2009.